1-9 of 9
D. Couriel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prophylaxis of Graft-Versus-Host Disease (GVHD) with Pentostatin, Tacrolimus, and “Mini”-Methotrexate (MTX): A Phase I/II Controlled, Randomized Study in Unrelated Donor (UD) Transplantation.

Marcos de Lima, B. Andersson, M. Fernadez-Vina, S. Giralt, D. Couriel, E. Shpall, U. Popat, M. Qazilbash, A. Alousi, P. Cano, D. Bosque, C. Hosing, S. Qureshi, L. de Padua, M. Munsell, P. Anderlini, R. Jones, M. Westmoreland, A. Gulbis, R. Champlin
Journal: Blood
Blood (2007) 110 (11): 40.
https://doi.org/10.1182/blood.V110.11.40.40
Published: 2007
Journal Articles

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Marcos De Lima, X. Wang, P.F. Thall, D. Couriel, R.B. Jones, E.J. Shpall, U. Popat, S. Giralt, M. Korbling, R. Champlin, B.S. Andersson
Journal: Blood
Blood (2006) 108 (11): 322.
https://doi.org/10.1182/blood.V108.11.322.322
Published: 2006
Journal Articles

Influence of Allele Level HLA Typing on Unrelated Donor (UD) Transplantation for High Risk Myeloid Leukemias.

S. Parmar, M. Fernandez-Vina, P. Liu, P. Cano, B. S. Andersson, M. Munsell, S. Giralt, J. McMannis, E. J. Shpall, D. Couriel, S. Ghosh, R. Champlin, M. de Lima
Journal: Blood
Blood (2005) 106 (11): 2916.
https://doi.org/10.1182/blood.V106.11.2916.2916
Published: 2005
Journal Articles

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Fludarabine and Melphalan (FM) Reduced Intensity Conditioning (RIC) for High-Risk AML/MDS.

B. Oran, R. Saliba, S. Giralt, D. Couriel, A. Carrasco-Yalan, C. Hosing, M. Shahjahan, E. de Meis, A. Anagnostopoulos, P. Anderlini, S. Ghosh, I. Khouri, R. Champlin, M. de Lima
Journal: Blood
Blood (2005) 106 (11): 838.
https://doi.org/10.1182/blood.V106.11.838.838
Published: 2005
Journal Articles

Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.

Marcos de Lima, S. Giralt, Z. Caldera, G. McCormick, M. Qazilbash, P. Anderlini, E. J. Shpall, C. Hosing, M. Donato, S. Kornblau, I. Khouri, T. Martin, D. Couriel, R. Champlin
Journal: Blood
Blood (2005) 106 (11): 841.
https://doi.org/10.1182/blood.V106.11.841.841
Published: 2005
Journal Articles

Pentostatin, Tacrolimus, and “Mini”-Methotrexate for Graft-Versus-Host Disease (GVHD) Prophylaxis: A Phase I/II Controlled, Randomized Study.

M. de Lima, D. Couriel, M. Munsell, M. Westmoreland, H. Shah, J. deJesus, C. Hosing, S. Ghosh, P. Anderlini, J. Gajewski, B. Andersson, S. Kornblau, B. Hocking, C. Ippoliti, S. Giralt, E. Shpall, R. Champlin
Journal: Blood
Blood (2004) 104 (11): 727.
https://doi.org/10.1182/blood.V104.11.727.727
Published: 2004
Journal Articles

Transplantation of Cord Blood Expanded Ex Vivo with Copper Chelator.

E. Shpall, M. de Lima, K. Chan, R. Champlin, A. Gee, P. Thall, K. Komanduri, D. Couriel, B. Andersson, C. Hosing, S. Giralt, S. Safa Karandish, T. Tara Sadeghi, B. Muriera, T. Peled, F. Grynspan, A. Nagler, J. McMannis
Journal: Blood
Blood (2004) 104 (11): 982.
https://doi.org/10.1182/blood.V104.11.982.982
Published: 2004
Journal Articles

Phase I/II Study of Gemtuzumab Ozogamicin (GO), Fludarabine and Melphalan (FM) Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in AML/MDS.

M. de Lima, P. Thall, M. Shahjahan, W. Xuemei, D. Couriel, P. Anderlini, C. Hosing, M. Qazilbash, G. McCormick, C. Ippoliti, M. Donato, T. Martin, L. Metoyer, L. Griffin, P. Kebriaei, R. Champlin, S. Giralt
Journal: Blood
Blood (2004) 104 (11): 1824.
https://doi.org/10.1182/blood.V104.11.1824.1824
Published: 2004
Journal Articles

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

D Mavroudis, E Read, M Cottler-Fox, D Couriel, J Molldrem, C Carter, M Yu, C Dunbar, J Barrett
Journal: Blood
Blood (1996) 88 (8): 3223–3229.
https://doi.org/10.1182/blood.V88.8.3223.bloodjournal8883223
Published: 1996